These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 15298582)

  • 1. Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.
    Heuzenroeder L; Donnelly M; Haby MM; Mihalopoulos C; Rossell R; Carter R; Andrews G; Vos T
    Aust N Z J Psychiatry; 2004 Aug; 38(8):602-12. PubMed ID: 15298582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of cognitive behavioural therapy and selective serotonin reuptake inhibitors for major depression in children and adolescents.
    Haby MM; Tonge B; Littlefield L; Carter R; Vos T
    Aust N Z J Psychiatry; 2004 Aug; 38(8):579-91. PubMed ID: 15298580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatments in panic disorder in adults: a network meta-analysis.
    Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-efficacy of individual and combined treatments for panic disorder.
    McHugh RK; Otto MW; Barlow DH; Gorman JM; Shear MK; Woods SW
    J Clin Psychiatry; 2007 Jul; 68(7):1038-44. PubMed ID: 17685740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
    Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
    Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomic analysis of venlafaxine in the treatment of major depressive disorder.
    Einarson TR; Addis A; Iskedjian M
    Pharmacoeconomics; 1997 Aug; 12(2 Pt 2):286-96. PubMed ID: 10170453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of newer antidepressants for panic disorder.
    Gorman JM
    J Clin Psychiatry; 1997; 58 Suppl 14():54-8; discussion 59. PubMed ID: 9418747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating generalized anxiety disorder.
    Gorman JM
    J Clin Psychiatry; 2003; 64 Suppl 2():24-9. PubMed ID: 12625796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacoeconomics of venlafaxine in depression.
    Morrow TJ
    Am J Manag Care; 2001 Sep; 7(11 Suppl):S386-92. PubMed ID: 11570029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness of venlafaxine for the treatment of depression and anxiety. Bibliographic review].
    Baca Baldomero E; Rubio-Terrés C
    Actas Esp Psiquiatr; 2006; 34(3):193-201. PubMed ID: 16736393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
    Griffiths RI; Sullivan EM; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    Pharmacoeconomics; 1999 May; 15(5):495-505. PubMed ID: 10537966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia.
    Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Panic Disorder and Agoraphobia
    Aust N Z J Psychiatry; 2003 Dec; 37(6):641-56. PubMed ID: 14636376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Panic disorder and antidepressants].
    Tsuboi K; Masuko M
    Nihon Rinsho; 2001 Aug; 59(8):1592-8. PubMed ID: 11519166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anxiety disorders: diagnosis and therapy from the family physician's perspective].
    Boerner RJ
    MMW Fortschr Med; 2006 May; Spec no. 2():62, 64-6. PubMed ID: 20104717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
    Trivedi MH; Wan GJ; Mallick R; Chen J; Casciano R; Geissler EC; Panish JM
    J Clin Psychopharmacol; 2004 Oct; 24(5):497-506. PubMed ID: 15349005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder.
    Katon WJ; Roy-Byrne P; Russo J; Cowley D
    Arch Gen Psychiatry; 2002 Dec; 59(12):1098-104. PubMed ID: 12470125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is implementation of the 2013 Australian treatment guidelines for posttraumatic stress disorder cost-effective compared to current practice? A cost-utility analysis using QALYs and DALYs.
    Mihalopoulos C; Magnus A; Lal A; Dell L; Forbes D; Phelps A
    Aust N Z J Psychiatry; 2015 Apr; 49(4):360-76. PubMed ID: 25348698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of antidepressants currently used to treat anxiety disorders.
    Feighner JP
    J Clin Psychiatry; 1999; 60 Suppl 22():18-22. PubMed ID: 10634351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.